Provided by Tiger Fintech (Singapore) Pte. Ltd.

bluebird bio

3.90
-0.2400-5.80%
Post-market: 3.900.00000.00%16:05 EDT
Volume:101.47K
Turnover:400.73K
Market Cap:38.18M
PE:-0.16
High:4.13
Open:4.13
Low:3.83
Close:4.14
Loading ...

JOHNNIE WALKER ESTABLISHES A NEW STANDARD IN DESIGN INNOVATION BY INTRODUCING BLUE LABEL ULTRA, THE WORLD'S LIGHTEST WHISKY BOTTLE

PR Newswire
·
18 Apr

BUZZ-U.S. STOCKS ON THE MOVE-Grocery Outlet, Abbott, General Dynamics

Reuters
·
17 Apr

Bluebird Bio Reaffirms Support for Carlyle Deal Amid Lack of Binding Offer From Ayrmid

MT Newswires Live
·
16 Apr

Shares of bluebird bio Down 9% After Ayrmid Fails to Give Binding Offer

THOMSON REUTERS
·
16 Apr

BUZZ-Bluebird Bio falls after Ayrmid fails to give binding offer

Reuters
·
16 Apr

bluebird bio Shares Down 7.9% at $4.12 Premarket After Ayrmid Fails to Give Binding Offer

THOMSON REUTERS
·
16 Apr

BRIEF-Bluebird Bio Confirms That Ayrmid, Has Not Delivered A Binding Offer Or Obtained Necessary Financing Despite Extensive Engagement

Reuters
·
16 Apr

Biotech Stock Roundup: CORT Up on Study Data, Updates From AXSM, BMY, EXEL & More

Zacks
·
03 Apr

BRIEF-Xcellbio Granted Bluebird Bio Commercial License, Got Into Supply Agreement For Use Of Co's Proprietary Cell Manufacturing Technology, Avatar

Reuters
·
02 Apr

Xcellbio: Granted bluebird bio Commercial License, Got Into Supply Agreement for Use of Co's Proprietary Cell Manufacturing Technology, Avatar

THOMSON REUTERS
·
02 Apr

BUZZ-U.S. STOCKS ON THE MOVE-Veritex, Gaming and Leisure Properties, Apple

Reuters
·
01 Apr

bluebird bio Is Maintained at Overweight by Barclays

Dow Jones
·
31 Mar

Bluebird Bio Shares Rise After Non-Binding Offer From Ayrmid

Dow Jones
·
31 Mar

BUZZ-U.S. STOCKS ON THE MOVE-Gene therapy cos, gold miners, chipmakers

Reuters
·
31 Mar

BUZZ-Bluebird bio rises on non-binding bid for up to $110.5 million

Reuters
·
31 Mar

Bluebird bio receives non-binding bid for up to $110.5 million

Reuters
·
29 Mar

BUZZ-Bluebird Bio shares rally 11% in late trade on buyout offer

Reuters
·
29 Mar

Bluebird Bio Reviewing Competing Buyout Offer From Ayrmid for Up to $110.5 Million

Dow Jones
·
29 Mar

Bluebird Bio Gets Rival Buyout Proposal From Ayrmid; Shares Jump After Hours

MT Newswires Live
·
29 Mar

BRIEF-Bluebird Bio Confirms Receipt Of An Unsolicited Non-Binding Proposal From Ayrmid

Reuters
·
29 Mar